Why the study?
What is the optimal treatment and current situation in reperfusion after thrombolysis for acute myocardial infarction?
What is the optimal treatment and current situation in reperfusion after thrombolysis for acute myocardial infarction?
This review highlights that while fibrinolytic therapy is critical for hospitals without emergent PCI capabilities, its success rate is limited, and comprehensive adjunctive and secondary preventive measures are essential.
No takes yet. Share an insight, caveat, or question.
Modest fibrinolytic success in AMI without PCI access warrants caution; review leaves open whether adjunctives can substantially improve outcomes.
Dauterman et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: